This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Jin Hee Kang: Innovator in Rheumatoid Arthritis Treatment
Introduction
Jin Hee Kang is a notable inventor based in Daegu, South Korea. She has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments for inflammatory diseases.
Latest Patents
Jin Hee Kang holds a patent for a fusion peptide comprising a dhFas-1 domain and MMP substrate, aimed at preventing and treating rheumatoid arthritis. The invention specifically relates to a fusion peptide that includes a dhFas-1 domain, which is the fourth fas-1 domain of βig-h3 lacking H1 and H2 regions, and a Matrix metalloproteinase (MMP) substrate. This fusion peptide is designed to inhibit the expansion of rheumatoid arthritis by affecting the adhesion and migration of synoviocytes. It may also be utilized for preventing or treating inflammatory diseases by inhibiting the infiltration of immune cells.
Career Highlights
Jin Hee Kang is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. Her work focuses on the intersection of academic research and practical applications in the medical field.
Collaborations
She collaborates with notable colleagues, including Young Mo Kang and In San Kim, who contribute to her research endeavors.
Conclusion
Jin Hee Kang's innovative work in developing treatments for rheumatoid arthritis showcases her commitment to advancing medical science. Her contributions are vital in the ongoing fight against inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile